1. The Emerging Role of Epigenetics in Inflammation and Immunometabolism
   Sukanya Raghuraman et al, 2016, Trends in Endocrinology & Metabolism CrossRef
2. Schisandra chinensis berry extract protects against steatosis by inhibiting histone acetylation in oleic acid–treated HepG2 cells and in the livers of diet-induced obese mice
   Min-Yu Chung et al, 2017, Nutrition Research CrossRef
3. Liver Adiposity and Metabolic Profile in Individuals with Chronic Spinal Cord Injury
   Kathleen C. Rankin et al, 2017, BioMed Research International CrossRef
4. TEMPORARY REMOVAL: Epigenetics in Chronic Liver Disease
   Marie Boyle et al, 2017, Journal of Hepatology CrossRef
5. Interplay among H3K9-editing enzymes SUV39H1, JMJD2C and SRC-1 drives p66Shc transcription and vascular oxidative stress in obesity
   Sarah Costantino et al, 2017 CrossRef
6. Potential Epigenetic Mechanism in Non-Alcoholic Fatty Liver Disease
   Chao Sun et al, 2015, IJMS CrossRef
7. Tannic acid, a new novel histone acetyltransferase inhibitor, prevents non-alcoholic fatty liver disease both in vivo and in vitro model
   Min-Yu Chung et al, 2018, Molecular Metabolism CrossRef
8. Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases
   Sabrina Campisano et al, 2019, Nutr. Res. Rev. CrossRef
9. Role of Histone Acetylation and Methylation in Obesity
   Lu Xu et al, 2019, Curr Pharmacol Rep CrossRef
10. Endocrine-disrupting chemicals and fatty liver disease
    Charles E. Foulds et al, 2017, Nat Rev Endocrinol CrossRef
11. Free fatty acid-induced histone acetyltransferase activity accelerates lipid accumulation in HepG2 cells
    Sangwon Chung et al, 2019, Nutr Res Pract CrossRef
12. The differential effects of low birth weight and Western diet consumption upon early life hepatic fibrosis development in guinea pig
    Ousseynou Sarr et al, 2016, J Physiol CrossRef
13. null
    A. Lopomo et al, 2016 CrossRef
14. null
    Ruifang Li et al, 2016 CrossRef
15. null
    Kimberley D. Bruce et al, 2016 CrossRef
16. Dietary natural products as epigenetic modifiers in aging-associated inflammation and disease
    Levi W. Evans et al, 2020, Nat. Prod. Rep. CrossRef
17. Regulation of Thermogenic Adipocyte Differentiation and Adaptive Thermogenesis Through Histone Acetylation
    Belinda X. Ong et al, 2020, Front. Endocrinol. CrossRef
18. The role of epigenetics in the development of obesity
    Arnaud Obri et al, 2020, Biochemical Pharmacology CrossRef
19. Metabolic regulation of kisspeptin — the link between energy balance and reproduction
    Víctor M. Navarro, 2020, Nat Rev Endocrinol CrossRef
20. Developmental programming: Prenatal testosterone induced changes in epigenetic modulators and gene expression in metabolic tissues of female sheep
    Xingzi Guo et al, 2020, Molecular and Cellular Endocrinology CrossRef
21. null
    Ahmed El-Serafi et al, 2020 CrossRef
22. The progress of epigenetics in the development and progression of non-alcoholic fatty liver disease☆
    Fen Xu et al, 2020, Liver Research CrossRef
23. The Role of Histone Acetylation-/Methylation-Mediated Apoptotic Gene Regulation in Hepatocellular Carcinoma
    Pradeep Kumar Rajan et al, 2020, IJMS CrossRef
24. Epigenetic Regulation of Adipogenesis in Development of Metabolic Syndrome
    Richa Pant et al, 2021, Front. Cell Dev. Biol. CrossRef
25. The Anti-Inflammatory Properties of Phytochemicals and Their Effects on Epigenetic Mechanisms Involved in TLR4/NF-κB-Mediated Inflammation
    Haidy A. Saleh et al, 2021, Front. Immunol. CrossRef
26. null
    Tomohiro Suzuki et al, 2021 CrossRef
27. An Overview of Epigenetics in Obesity: The Role of Lifestyle and Therapeutic Interventions
    Abeer M. Mahmoud, 2022, IJMS CrossRef
28. BAM15, a Mitochondrial Uncoupling Agent, Attenuates Inflammation in the LPS Injection Mouse Model: An Adjunctive Anti-Inflammation on Macrophages and Hepatocytes
    Cong Phi Dang et al, 2021, J Innate Immun CrossRef
29. Epigenetic Aspects and Prospects in Autoimmune Hepatitis
    Albert J. Czaja, 2022, Front. Immunol. CrossRef
30. Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 Diabetes
    Federica Zatterale et al, 2022, Biomolecules CrossRef
31. Developmental modeling of hepatogenesis using obese iPSCs-hepatocyte differentiation uncovers pathological features
    Divya Saro Varghese et al, 2022, Cell Death Dis CrossRef
32. Epigenetics and mitochondrial dysfunction insights into the impact of the progression of non‐alcoholic fatty liver disease
    Shreyoshi Guha et al, 2022, Cell Biochemistry & Function CrossRef
33. Therapeutic potential of gallic acid in obesity: Considerable shift!
    Prabhat Kumar Behera et al, 2022, Obesity Medicine CrossRef
34. The Potential Role of Gut Microbiota in the Pathogenesis of Type 2 Diabetes Mellitus via Epigenetics and Inflammasome
    Bunty Sharma et al, 2022, EMIDDT CrossRef
35. Palmitate Potentiates Lipopolysaccharide-Induced IL-6 Production via Coordinated Acetylation of H3K9/H3K18, p300, and RNA Polymerase II
    Shihab Kochumon et al, 2022 CrossRef
36. Genetics and epigenetics in the obesity phenotyping scenario
    Khanh Trang et al, 2023, Rev Endocr Metab Disord CrossRef
37. null
    Ana L. Santos et al, 2023 CrossRef
38. Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies
    Xiumei Wu et al, 2023, Sig Transduct Target Ther CrossRef
39. Plant-Derived Nutraceuticals Involved in Body Weight Control by Modulating Gene Expression
    Maria Vrânceanu et al, 2023, Plants CrossRef
40. null
    Imad Soukar et al, 2023 CrossRef
41. Tributyrin Mitigates Ethanol-Induced Lysine Acetylation of Histone-H3 and p65-NFκB Downregulating CCL2 Expression and Consequent Liver Inflammation and Injury
    Smita S. Ghare et al, 2023, Nutrients CrossRef
42. Assessment of global histone acetylation in pediatric and adolescent obesity: Correlations with SIRT1 expression and metabolic-inflammatory profiles
    Nima Taghizadeh et al, 2023, PLoS ONE CrossRef
43. A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression
    Meysam Ramezani et al, 2023, Pathology - Research and Practice CrossRef
44. Traditional Therapeutics and Potential Epidrugs for CVD: Why Not Both?
    Lauren Rae Gladwell et al, 2023, Life CrossRef
45. Robinetin Alleviates Metabolic Failure in Liver through Suppression of p300–CD38 Axis
    Ji-Hye Song et al, 2024, Biomol Ther (Seoul) CrossRef
46. Sex-based differences in short- and longer-term diet-induced metabolic heart disease
    Amanda J. Croft et al, 2024, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
47. KAT8 beyond Acetylation: A Survey of Its Epigenetic Regulation, Genetic Variability, and Implications for Human Health
    Lindsey Yoo et al, 2024, Genes CrossRef
48. The complex web of obesity: from genetics to precision medicine
    Janaki Nair M et al, 2024, Expert Review of Endocrinology & Metabolism CrossRef
49. TNF-α/Stearate Induced H3K9/18 Histone Acetylation Amplifies IL-6 Expression in 3T3-L1 Mouse Adipocytes
    Fatemah Bahman et al, 2024, IJMS CrossRef